Use of breast surveillance between women with pathogenic variants and variants of uncertain significance in breast cancer susceptibility genes-Reference-Cited by-同舟云学术

Use of breast surveillance between women with pathogenic variants and variants of uncertain significance in breast cancer susceptibility genes

Published:2022-08-23 Issue:20 Volume:128 Page:3709-3717
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Makhnoon Sukh¹^ORCID,Chen Minxing²,Levin Brooke³,Ensinger Megan⁴,Mattie Kristin D.³,Grana Generosa³,Shete Sanjay⁵^ORCID,Arun Banu K.⁶^ORCID,Peterson Susan K.¹

Affiliation:

1. Department of Behavioral Science The University of Texas MD Anderson Cancer Center Houston Texas USA

2. Department of Biostatistics The University of Texas MD Anderson Cancer Center Houston Texas USA

3. William G. Rohrer Cancer Genetics Program, Division of Hematology and Medical Oncology MD Anderson Cancer Center at Cooper University Health Care Camden New Jersey USA

4. OhioHealth Cancer Genetics Program OhioHealth Columbus Ohio USA

5. Division of Cancer Prevention and Population Sciences The University of Texas MD Anderson Cancer Center Houston Texas USA

6. Breast Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA

Funder

National Cancer Institute

National Institutes of Health

Cancer Prevention and Research Institute of Texas

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34429

Reference27 articles.

1. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

2. What’s the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer

3. Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors

4. Mammography Surveillance Following Breast Cancer

5. Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing;Peshkin BN;Cancer Epidemiol Biomarkers Prev,2002

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein-folding chaperones predict structure-function relationships and cancer risk in BRCA1 mutation carriers;Cell Reports;2024-02

2. Protein-Folding Chaperones Predict Structure-Function Relationships and Cancer Risk inBRCA1Mutation Carriers;2023-09-15

3. Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study;Cancer Medicine;2023-08-30

4. Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system;Breast Cancer Research and Treatment;2023-07-20